Company: JUNS
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010990
Chunk: 45

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Item 8
Chunk 45
---
5  
     1,359,375  
    $0.80  
     0.68 

    19

JUPITER NEUROSCIENCES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2025

Note 6 – Stockholders’ Equity,
continued

Restricted Stock Units

As of March 31, 2025 and December 31, 2024 the Company had an
aggregate of 1,626,037
restricted stock units outstanding with an aggregate fair value of $2,195,550.

Note 7 – Commitments and Contingencies

Legal Matters

From time to time, claims are made against the
Company in the ordinary course of business, which could result in legal proceedings. Claims and associated litigation are subject to inherent
uncertainties and unfavorable outcomes could occur, which could have a material adverse effect on the Company’s results of operations
for that period or future periods. As of March 31, 2025, there were no pending or outstanding legal proceedings.

    20

JUPITER NEUROSCIENCES, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2025

Note 7 – Commitments and Contingencies,
continued

Office Lease

On May 1, 2021, the Company entered into a 61-month
operating lease for office space for a base rent of $3,783 subject to a 3% yearly escalation.

As of March 31, 2025 and December 31, 2024, the
Company’s operating lease right-of-use asset, net (ROU) is $58,035
and $69,642, respectively. Related
lease liability totaled $59,063 and $71,329,
respectively, based on an incremental borrowing rate at lease inception.

Schedule
of Operating Lease Right-of-use Asset and  Liability

    March 31,  
    December 31, 

    2025  
    2024 
  
    Operating lease right-of-use asset  is summarized below: 

    Right-of-use asset 
    $236,009  
    $236,009 
  
    Less accumulated amortization 
     (177,974) 
     (166,367)
  
    Right-of-use asset, net 
    $58,035